# Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System

> **NCT04327999** · PHASE2 · TERMINATED · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 9 (actual)

## Conditions studied

- Thyroid Carcinoma
- Radioactive Iodine Level

## Interventions

- **DRUG:** Artificial Tears

## Key facts

- **NCT ID:** NCT04327999
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-10-05
- **Primary completion:** 2023-09-25
- **Final completion:** 2023-09-25
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Funding ended
- **Last updated:** 2024-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04327999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04327999, "Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04327999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*